Mitral valve calcium assessment: An independent predictor of balloon valvuloplasty results
Autor: | Martín Oscos, Gerardo Gigena, Federico Giachello, Federico Blanco, Pablo Pedroni, Agustín Hauqui, Raúl Solernó, Rodrigo Blanco, Jorge A. Lax, Ricardo Sarmiento |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
Adult
Balloon Valvuloplasty Male medicine.medical_specialty Percutaneous Multivariate analysis RD1-811 Mitral valvuloplasty 030204 cardiovascular system & hematology Independent predictor 03 medical and health sciences 0302 clinical medicine Mitral valve stenosis Restenosis Internal medicine Mitral valve medicine Humans Mitral Valve Stenosis Diseases of the circulatory (Cardiovascular) system 030212 general & internal medicine Mitral valve calcification business.industry Calcinosis Middle Aged medicine.disease Treatment Outcome medicine.anatomical_structure Echocardiography Originaln Article Valve calcification RC666-701 Cardiology Mitral Valve Female Surgery Cardiology and Cardiovascular Medicine business |
Zdroj: | Indian Heart Journal, Vol 71, Iss 6, Pp 454-458 (2019) Indian Heart Journal |
ISSN: | 0019-4832 |
Popis: | Objective: Percutaneous mitral valvuloplasty (PMV) is an effective treatment for patients with mitral valve stenosis. Echocardiographic score (ES) is a useful predictor of outcomes. However, mitral valve calcification (MVC) has been shown to predict immediate results even in patients with otherwise low ES. We sought to evaluate the usefulness of MVC assessment as a predictor of immediate and long-term outcomes after PMV. Methods: PMV was performed in 168 consecutive patients. Clinical and echocardiographic variables were analyzed. Patients were classified into 2 groups: group 1: minimal MVC and group 2: moderate to severe MVC. Primary success was defined as post-PMV mitral valve area (MVA) ≥ 1.5 cm2 in the absence of major complications. Restenosis (RE) was defined as a decrease in MVA >50% of initial gain or a final MVA |
Databáze: | OpenAIRE |
Externí odkaz: |